《大行》高盛升商湯(00020.HK)目標價至3.53元 已獲多張生成式AI訂單
高盛研究報告指,商湯(00020.HK)最新項目消息顯示,其已從教育、醫療、媒體、金融、交通等領域的企業(ToB)與政府(ToG)客戶中,獲得生成式AI新項目訂單。該行預期未來項目將加速增長,主要受惠於內地雲端資本開支提升,以及8月公布的「AI+」行動方案等利好政策推動。
該行認為,商湯可針對不同客戶需求,提供覆蓋算力、大規模AI基礎設施、AI基礎模型,以及生成式AI應用的全套解決方案能力;並料公司未來幾年將繼續專注於大型項目,以確保更高效率並提高收入。
該行下調2026及27年淨虧損預測至9.51億元及1.94億元人民幣,並上調2028至30年盈利預測1%、1%及2%;維持「買入」評級,目標價由3.09港元升至3.53港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.